Jun Shao

Latest

• Comment on FDA draft guidance for industry FDA-2019-D-0934: Adjusting for covariates in randomized clinical trials for drugs and biological products
• Toward Better Practice of Covariate Adjustment in Analyzing Randomized Clinical Trials